Literature DB >> 19053315

Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes.

Socorro Espuelas1, Christine Thumann, Béatrice Heurtault, Francis Schuber, Benoît Frisch.   

Abstract

An important challenge for the development of new generations of vaccines is the efficient delivery of antigens to antigen presenting cells such as dendritic cells. In the present study we compare the interaction of plain and targeted liposomes, containing mono-, di-, and tetraantennary mannosyl lipid derivatives, with human monocyte-derived immature dendritic cells (iDCs). Whereas efficient mannose receptor-mediated endocytosis by iDCs was observed for the mannosylated liposomes, in contrast, only nonspecific interaction with little uptake was observed with plain liposomes. In accordance with the clustering effect, liposomes prepared with multibranched mannosylated lipids displayed higher binding affinity for the mannose receptor than vesicles containing the monomannosylated analogs. Importantly, we have found that dimannosylated ligands present at the surface of the liposomes were as efficient as tetramannosylated ones to engage in multidentate interactions with the mannose receptor of iDCs, resulting in both cases in an effective uptake/endocytosis. This result will greatly facilitate, from a practical standpoint, the design of mannose-targeted vaccination constructs. Moreover, we showed that mannose-mediated uptake of liposomes did not result in an activation of iDCs. Altogether, our results suggest that antigen-associated targeted liposomes containing diantennary mannosylated lipids could be effective vectors for vaccines when combined with additional DC activation signals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053315     DOI: 10.1021/bc8002524

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  18 in total

1.  Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.

Authors:  Samar Hamdy; Azita Haddadi; Anooshirvan Shayeganpour; John Samuel; Afsaneh Lavasanifar
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

Review 2.  mRNA vaccine delivery using lipid nanoparticles.

Authors:  Andreas M Reichmuth; Matthias A Oberli; Ana Jaklenec; Robert Langer; Daniel Blankschtein
Journal:  Ther Deliv       Date:  2016

3.  The impact of nanoparticle ligand density on dendritic-cell targeted vaccines.

Authors:  Arunima Bandyopadhyay; Rebecca L Fine; Stacey Demento; Linda K Bockenstedt; Tarek M Fahmy
Journal:  Biomaterials       Date:  2011-01-22       Impact factor: 12.479

Review 4.  Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.

Authors:  Stacey L Demento; Alyssa L Siefert; Arunima Bandyopadhyay; Fiona A Sharp; Tarek M Fahmy
Journal:  Trends Biotechnol       Date:  2011-04-02       Impact factor: 19.536

5.  Effective targeted gene delivery to dendritic cells via synergetic interaction of mannosylated lipid with DOPE and BCAT.

Authors:  Hee-Kwon Kim; Huiling Wei; Aditya Kulkarni; Roman M Pogranichniy; David H Thompson
Journal:  Biomacromolecules       Date:  2012-01-09       Impact factor: 6.988

Review 6.  Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines.

Authors:  Hayk Davtyan; Andrew Bacon; Irina Petrushina; Karen Zagorski; David H Cribbs; Anahit Ghochikyan; Michael G Agadjanyan
Journal:  Hum Vaccin Immunother       Date:  2014-02-13       Impact factor: 3.452

7.  Targeted liposomal drug delivery to monocytes and macrophages.

Authors:  Ciara Kelly; Caroline Jefferies; Sally-Ann Cryan
Journal:  J Drug Deliv       Date:  2010-10-26

Review 8.  Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review.

Authors:  Ehsan Raoufi; Bahar Bahramimeimandi; M Salehi-Shadkami; Patcharida Chaosri; M R Mozafari
Journal:  Biomedicines       Date:  2021-05-06

9.  Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses.

Authors:  Gustaf Ahlén; Lena Strindelius; Tomas Johansson; Anki Nilsson; Nathalie Chatzissavidou; Magnus Sjöblom; Ulrika Rova; Jan Holgersson
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

10.  C-type Lectin Receptors for Tumor Eradication: Future Directions.

Authors:  Ingeborg Streng-Ouwehand; Wendy W J Unger; Yvette Van Kooyk
Journal:  Cancers (Basel)       Date:  2011-08-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.